Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2002;55:575-576; doi:10.1136/jcp.55.8.575
Copyright © 2002 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Journal of Clinical Pathology 2002;55:575-576
© 2002 Journal of Clinical Pathology

EDITORIAL

Tissue microarrays

Tissue microarrays for predictive molecular pathology

G Sauter, M Mirlacher

Institute of Pathology, University of Basel, Schönbeinstrasse 40, CH-4031 Basel, Switzerland

Correspondence to:
Correspondence to:
Dr G Sauter, Institute of Pathology, University of Basel, Schoenbeinstrasse 40, CH-4031 Basel, Switzerland;
Guido.Sauter@unibas.ch


Preparing for a TITANIC problem

Keywords: immunohistochemistry; tissue microarray; quality control

The first 150 words of the full text of this article appear below.

The advent of a novel category of anticancer drugs targeting individual genes is greatly affecting pathology and it appears that a new discipline—predictive molecular pathology—will become important in our field. For example, Herceptin (trastuzamab) treatment can only be used against tumours expressing the HER-2 oncogene1 and STI571 (Glivec) is highly efficient against tumours expressing c-kit (CD117).2 Because these target genes can be expressed in many different tumour types, oncologists are now increasingly demanding HER-2 and c-kit analyses for all of their patients so that they can potentially benefit from new drugs. The number of such analyses, often performed many years after the removal of the primary tumour, increases rapidly as more patients with cancer and clinicians become aware of the potential availability of new "miracle" drugs. Currently, the demand for retrospective c-kit and HER-2 analyses can be met using the tools of traditional molecular pathology.

However, what would . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Blind, C, Koepenik, A, Pacyna-Gengelbach, M, Fernahl, G, Deutschmann, N, Dietel, M, Krenn, V, Petersen, I (2008). Antigenicity testing by immunohistochemistry after tissue oxidation. J. Clin. Pathol. 61: 79-83 [Abstract] [Full Text]  
  • Sauter, G., Simon, R., Al-Kuraya, K., Terracciano, L. (2005). In Reply:. JCO 23: 5271-5272 [Full Text]  
  • Packeisen, J, Korsching, E, Herbst, H, Boecker, W, Buerger, H (2003). Demystified ... Tissue microarray technology. Mol. Pathol. 56: 198-204 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs